Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CLS vs GSK✓SelectedUSD · GSKCLS vs GSK performance historyLatest closeAs of-16.00%11/20
Stock and ETF performance explorer

CLS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-28.5%
GSK return
+6.1%
Excess return
-34.7%
Maximum drawdown
-57.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-16.0%-0.1%-15.9%-16.0%
7D-16.0%-5.3%-10.7%-17.9%
30D-33.8%-3.7%-30.1%-34.3%
3M-33.2%-7.3%-25.9%-33.4%
6M-41.8%-4.2%-37.5%-41.7%
YTD-31.7%+0.9%-32.6%-28.3%
1Y-28.5%+7.3%-35.8%-26.0%
All-28.5%+6.1%-34.7%-26.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling